CLGN logo

CollPlant Biotechnologies Ltd. (CLGN)

Profile

Full Name

CollPlant Biotechnologies Ltd.

Ticker

NASDAQ: CLGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

January 31, 2018

Indexes

Not included

Website

https://collplant.com

Employees

57

Key Details

Price

$2.22(0.00%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$515.00K(-95.30% YoY)

Annual EPS

-$1.45(-135.28% YoY)

PE Ratio

-

Next earnings date

Nov 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.22
    CLGN price is $2.22

    30-Day Relative Volume

    0.63
    CLGN 30-day relative volume is 0.63

    Price Performance

    Price Most Recent Change

    0%
    CLGN price has remained unchanged on Nov 24, 2025

    Price YTD Change

    -38.33%
    CLGN price is down -38.33% since January 1st

    Price 1-Year Change

    -47.86%
    CLGN price is down -47.86% year-on-year

    Price 3-Year Change

    -52.87%
    CLGN price is down -52.87% over the past 3 years

    Price Range

    Price All-Time High

    $24.26
    CLGN price is currently -90.85% below its historical high of $24.26

    Price 3-Year Low

    $1.31
    CLGN price is currently +69.47% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $28.23M
    CLGN market cap is $28.23 million

    Market Cap 3-Year Change

    -45.94%
    CLGN market cap is down -45.94% over the past 3 years

    Market Cap All-Time High

    $240.35M
    CLGN market cap is currently -88.25% below its historical high of $240.35 million

    Market Cap Sector Percentile

    26.7%
    CLGN market cap is higher than 26.7% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11.01%
    CLGN shares outstanding is up +11.01% year-on-year

    Shares Outstanding 3-Year Change

    +14.7%
    CLGN shares outstanding is up +14.7% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.39
    CLGN beta is 0.39

    200-day SMA

    $2.40
    CLGN price is currently -7.67% below its 200-day simple moving average

    50-day SMA

    $2.33
    CLGN price is currently -4.75% below its 50-day simple moving average

    14-Day RSI

    52.54
    CLGN 14-day relative strength index is 52.54

    Volume

    0.63
    CLGN 30-day relative volume is 0.63

    ATR

    $0.16
    CLGN average true range is $0.16

    10-day Historical Volatility

    50.82%
    CLGN 10-day historical volatility is 50.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $515.00K
    CLGN annual revenue is $515.00 thousand

    Revenue Analysts Estimate

    $29.30M
    CLGN annual revenue is currently -98.24% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -95.3%
    CLGN annual revenue is down -95.3% year-on-year

    Revenue Sector Percentile

    34.85%
    CLGN annual revenue is higher than 34.85% of companies in Healthcare sector

    EPS

    EPS

    -$1.45
    CLGN annual earnings per share is -$1.45

    EPS Analysts Estimate

    -$0.32
    CLGN annual earnings per share is currently -360.32% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -135.28%
    CLGN annual earnings per share is down -135.28% year-on-year

    EPS Sector Percentile

    46.38%
    CLGN annual earnings per share is higher than 46.38% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.15M
    CLGN annual gross profit is -$2.15 million

    Gross Margin

    -417.09%
    CLGN annual gross profit margin is -417.09%

    Operating Profit

    -$17.25M
    CLGN annual operating income is -$17.25 million

    Operating Margin

    -3349.71%
    CLGN annual operating profit margin is -3349.71%

    Net Income

    -$16.61M
    CLGN annual net profit is -$16.61 million

    Net Margin

    -3225.05%
    CLGN annual net profit margin is -3225.05%

    Expenses

    Total Expenses

    $17.12M
    CLGN annual total expenses is $17.12 million

    Operating Expenses

    $15.10M
    CLGN annual total operating expenses is $15.10 million

    Cost Of Goods Sold

    $2.66M
    CLGN annual cost of goods sold is $2.66 million

    Selling, General & Administrative Expenses

    $0.00
    CLGN annual SG&A is $0.00

    Depreciation & Amortization

    $1.04M
    CLGN annual D&A is $1.04 million

    Interest Expense

    $0.00
    CLGN annual interest expense is $0.00

    Income Tax

    $0.00
    CLGN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$17.25M
    CLGN annual earnings before interest & taxes is -$17.25 million

    EBITDA

    -$16.21M
    CLGN annual EBITDA is -$16.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $18.71M
    CLGN annual total assets is $18.71 million

    Non Current Assets

    $5.53M
    CLGN annual long term assets is $5.53 million

    Current Assets

    $13.18M
    CLGN annual total current assets is $13.18 million

    Cash and Cash Equivalents

    $12.16M
    CLGN annual cash & cash equivalents is $12.16 million

    Accounts Receivable

    $150.00K
    CLGN annual accounts receivable is $150.00 thousand

    Inventory

    $440.00K
    CLGN annual inventory is $440.00 thousand

    Liabilities

    Total Liabilities

    $5.25M
    CLGN annual total liabilities is $5.25 million

    Long Term Liabilities

    $2.27M
    CLGN annual total long term liabilities is $2.27 million

    Current Liabilities

    $2.97M
    CLGN annual current liabilities is $2.97 million

    Accounts Payable

    $870.00K
    CLGN annual accounts payable is $870.00 thousand

    Debt

    Total Debt

    $3.08M
    CLGN annual total debt is $3.08 million

    Total Debt 1-Year Change

    -2.47%
    CLGN annual total debt is down -2.47% year-on-year

    Long Term Debt

    $2.27M
    CLGN annual long term debt is $2.27 million

    Short Term Debt

    $806.00K
    CLGN annual short term debt is $806.00 thousand

    Equity & Capital

    Shareholders Equity

    $13.46M
    CLGN annual stockholders equity is $13.46 million

    Book Value

    $13.46M
    CLGN annual book value is $13.46 million

    Retained Earnings

    -$113.35M
    CLGN annual retained earnings is -$113.35 million

    Working Capital

    $10.21M
    CLGN annual working capital is $10.21 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$14.09M
    CLGN annual cash from operations is -$14.09 million

    Cash From Operations 1-Year Change

    -410.06%
    CLGN annual cash from operations is down -410.06% year-on-year

    Cash From Investing

    -$539.00K
    CLGN annual cash from investing is -$539.00 thousand

    Cash From Investing 1-Year Change

    +53.37%
    CLGN annual cash from investing is up +53.37% year-on-year

    Cash From Financing

    $9000.00
    CLGN annual cash from financing is $9000.00

    Cash From Financing 1-Year Change

    -99.19%
    CLGN annual cash from financing is down -99.19% year-on-year

    CAPEX

    CAPEX

    $483.00K
    CLGN annual capital expenditures is $483.00 thousand

    CAPEX 1-Year Change

    -49.37%
    CLGN annual capital expenditures is down -49.37% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$14.58M
    CLGN annual free cash flow is -$14.58 million

    Free Cash Flow 1-Year Change

    -292.14%
    CLGN annual free cash flow is down -292.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -417.09%
    CLGN annual gross profit margin is -417.09%

    Operating Margin

    -3349.71%
    CLGN annual operating profit margin is -3349.71%

    Net Margin

    -3225.05%
    CLGN annual net profit margin is -3225.05%

    ROA & ROE

    ROA

    -62.87%
    CLGN annual return on assets is -62.87%

    ROE

    -79.46%
    CLGN annual return on equity is -79.46%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CLGN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CLGN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.26
    CLGN price to book ratio is 2.26

    PB Ratio Sector Percentile

    54.35%
    CLGN price to book ratio is higher than 54.35% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    11.75
    CLGN price to sales ratio is 11.75

    PS Ratio Sector Percentile

    72.27%
    CLGN price to sales ratio is higher than 72.27% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $19.55M
    CLGN enterprise value is $19.55 million

    Enterprise Value Sector Percentile

    27.02%
    CLGN enterprise value is higher than 27.02% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.58
    CLGN EV/EBITDA is -1.58

    EV/EBITDA Sector Percentile

    40.98%
    CLGN EV/EBITDA is higher than 40.98% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.44
    CLGN annual current ratio is 4.44

    Quick Ratio

    4.29
    CLGN annual quick ratio is 4.29

    Leverage

    Debt To Equity

    0.23
    CLGN annual debt to equity ratio is 0.23

    Interest Coverage Ratio

    -
    CLGN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    CLGN piotroski f-score is 4

    Altman Z-Score

    -7.61
    CLGN altman z-score is -7.61

    Analyst ratings

    Recent major analysts updates

    Oct 20, 25 D. Boral Capital
    Buy
    Sep 16, 25 D. Boral Capital
    Buy
    Aug 21, 25 HC Wainwright & Co.
    Buy
    Aug 20, 25 D. Boral Capital
    Buy
    May 30, 25 D. Boral Capital
    Buy
    May 28, 25 D. Boral Capital
    Buy
    Mar 27, 25 D. Boral Capital
    Buy
    Feb 12, 25 D. Boral Capital
    Buy
    Feb 4, 25 D. Boral Capital
    Buy
    Nov 29, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CLGN included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings tomorrow
    Earnings this week
    • What is the ticker symbol for CollPlant Biotechnologies Ltd.?
    • Does CollPlant Biotechnologies Ltd. pay dividends?
    • What sector is CollPlant Biotechnologies Ltd. in?
    • What industry is CollPlant Biotechnologies Ltd. in?
    • What country is CollPlant Biotechnologies Ltd. based in?
    • When did CollPlant Biotechnologies Ltd. go public?
    • Is CollPlant Biotechnologies Ltd. in the S&P 500?
    • Is CollPlant Biotechnologies Ltd. in the NASDAQ 100?
    • Is CollPlant Biotechnologies Ltd. in the Dow Jones?
    • When was CollPlant Biotechnologies Ltd.'s last earnings report?
    • When does CollPlant Biotechnologies Ltd. report earnings?

    What is the ticker symbol for CollPlant Biotechnologies Ltd.?

    The ticker symbol for CollPlant Biotechnologies Ltd. is NASDAQ:CLGN

    Does CollPlant Biotechnologies Ltd. pay dividends?

    No, CollPlant Biotechnologies Ltd. does not pay dividends

    What sector is CollPlant Biotechnologies Ltd. in?

    CollPlant Biotechnologies Ltd. is in the Healthcare sector

    What industry is CollPlant Biotechnologies Ltd. in?

    CollPlant Biotechnologies Ltd. is in the Biotechnology industry

    What country is CollPlant Biotechnologies Ltd. based in?

    CollPlant Biotechnologies Ltd. is headquartered in Israel

    When did CollPlant Biotechnologies Ltd. go public?

    CollPlant Biotechnologies Ltd.'s initial public offering (IPO) was on January 31, 2018

    Is CollPlant Biotechnologies Ltd. in the S&P 500?

    No, CollPlant Biotechnologies Ltd. is not included in the S&P 500 index

    Is CollPlant Biotechnologies Ltd. in the NASDAQ 100?

    No, CollPlant Biotechnologies Ltd. is not included in the NASDAQ 100 index

    Is CollPlant Biotechnologies Ltd. in the Dow Jones?

    No, CollPlant Biotechnologies Ltd. is not included in the Dow Jones index

    When was CollPlant Biotechnologies Ltd.'s last earnings report?

    CollPlant Biotechnologies Ltd.'s most recent earnings report was on August 20, 2025

    When does CollPlant Biotechnologies Ltd. report earnings?

    The next expected earnings date for CollPlant Biotechnologies Ltd. is November 26, 2025
    On this page